OPKO Health Inc.

Products

Category

Product

Brand

Description

Routine Health Screening Market (HLC299A)

PSA Testing		This test is used to screen for prostate cancer by measuring the amount of prostate-specific antigen (PSA) in blood.
4Kscore Test		This test accurately identifies an individual patient’s risk of having aggressive prostate cancer.
Hereditary Prostate Cancer Panel		Testing with the Hereditary Prostate Cancer Panel may be appropriate if a patient’s individual and family history is suggestive of a hereditary predisposition to prostate cancer. Genes tested for in this panel include ATM, BRCA1, BRCA2, BRIP1, CHEK2, EPCAM, HOXB13, MLH1, MSH2, MSH6, NBN, PALB2, PMS2, RAD51C, RAD51D, and TP53.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment